Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC decreased its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Rating) by 4.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,040,925 shares of the company’s stock after selling 49,273 shares during the period. Neuberger Berman Group LLC’s holdings in Acadia Healthcare were worth $68,217,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $38,000. Quent Capital LLC purchased a new position in shares of Acadia Healthcare during the 4th quarter valued at approximately $115,000. Tranquility Partners LLC purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $209,000. Walleye Capital LLC purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $216,000. Finally, Inspire Investing LLC purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $235,000. Hedge funds and other institutional investors own 99.79% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $82.00 in a report on Monday, August 1st. SVB Leerink raised their target price on Acadia Healthcare from $95.00 to $103.00 and gave the stock an “outperform” rating in a research note on Friday, August 26th. UBS Group raised their target price on Acadia Healthcare from $82.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Jefferies Financial Group raised their target price on Acadia Healthcare from $85.00 to $95.00 in a research note on Thursday, July 28th. Finally, Loop Capital assumed coverage on Acadia Healthcare in a research report on Thursday, June 16th. They set a “hold” rating and a $72.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.88.

Insider Buying and Selling at Acadia Healthcare

In other news, Director William M. Petrie sold 6,000 shares of Acadia Healthcare stock in a transaction dated Friday, July 29th. The stock was sold at an average price of $83.42, for a total value of $500,520.00. Following the completion of the transaction, the director now owns 31,769 shares in the company, valued at approximately $2,650,169.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director William Grieco sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $82.54, for a total transaction of $412,700.00. Following the completion of the sale, the director now owns 73,811 shares in the company, valued at $6,092,359.94. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William M. Petrie sold 6,000 shares of the business’s stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $83.42, for a total value of $500,520.00. Following the sale, the director now owns 31,769 shares of the company’s stock, valued at approximately $2,650,169.98. The disclosure for this sale can be found here. Insiders sold a total of 34,094 shares of company stock valued at $2,788,568 in the last three months. 1.90% of the stock is owned by corporate insiders.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $84.17 on Friday. The company has a market cap of $7.65 billion, a P/E ratio of 27.60, a P/E/G ratio of 2.01 and a beta of 1.28. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.17 and a quick ratio of 1.17. The stock has a 50-day moving average of $80.73 and a two-hundred day moving average of $72.97. Acadia Healthcare Company, Inc. has a 1-year low of $50.07 and a 1-year high of $86.75.

Acadia Healthcare (NASDAQ:ACHCGet Rating) last released its earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. The company had revenue of $651.72 million during the quarter, compared to the consensus estimate of $650.80 million. Acadia Healthcare had a return on equity of 10.34% and a net margin of 11.32%. Acadia Healthcare’s revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.71 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.08 EPS for the current year.

About Acadia Healthcare

(Get Rating)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.

Featured Stories

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Rating).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.